Lung Large Cell Carcinoma — Trials

Lung Large Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

33 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05566223	CISH Inactivated TILs in the Treatment of NSCLC(CheckCell-2)	withdrawn	Phase 1 / Phase 2	0	Intima Bioscience, Inc.INDUSTRY	1	Feb 23, 2026	clinicaltrials
NCT02059967	Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC	withdrawn	Phase 1	0	Virginia Commonwealth UniversityOTHER	0	Mar 19, 2015	clinicaltrials